BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 34272748)

  • 1. Pediatric morphea state-of-the-art literature review: Reframing morphea as a systemic disease.
    Sink JR; Chiu YE
    Pediatr Dermatol; 2021 Sep; 38(5):1020-1031. PubMed ID: 34272748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Juvenile localized scleroderma].
    Strauss T; Günther C; Brück N
    Dermatologie (Heidelb); 2024 Mar; 75(3):208-213. PubMed ID: 38240812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric morphea.
    Browning JC
    Dermatol Clin; 2013 Apr; 31(2):229-37. PubMed ID: 23557652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid for treatment of systemic sclerosis and morphea: A literature review.
    Thomas RM; Worswick S; Aleshin M
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 28032675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic and therapeutic problems of scleroderma].
    Pogorzelska-Antkowiak A; Antkowiak R
    Wiad Lek; 2006; 59(5-6):392-5. PubMed ID: 17017489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upcoming treatments for morphea.
    Wenzel D; Haddadi NS; Afshari K; Richmond JM; Rashighi M
    Immun Inflamm Dis; 2021 Dec; 9(4):1101-1145. PubMed ID: 34272836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphea and Eosinophilic Fasciitis: An Update.
    Mertens JS; Seyger MMB; Thurlings RM; Radstake TRDJ; de Jong EMGJ
    Am J Clin Dermatol; 2017 Aug; 18(4):491-512. PubMed ID: 28303481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric morphea (localized scleroderma): review of 136 patients.
    Christen-Zaech S; Hakim MD; Afsar FS; Paller AS
    J Am Acad Dermatol; 2008 Sep; 59(3):385-96. PubMed ID: 18571769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory arthritis in pediatric patients with morphea.
    Kashem SW; Correll CK; Vehe RK; Hobday PM; Binstadt BA; Maguiness SM
    J Am Acad Dermatol; 2018 Jul; 79(1):47-51.e2. PubMed ID: 29535035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene Expression Signatures in Inflammatory and Sclerotic Morphea Skin and Sera Distinguish Morphea from Systemic Sclerosis.
    Chen HW; Zhu JL; Martyanov V; Tsoi LC; Johnson ME; Barber G; Popovich D; O'Brien JC; Coias J; Cyrus N; Malviya N; Florez-Pollack S; Kunzler E; Hosler GA; Gudjonsson JE; Khanna D; Whitfield M; Jacobe HT
    J Invest Dermatol; 2023 Oct; 143(10):1886-1895.e10. PubMed ID: 37028702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous and subcutaneous inflammatory sclerosis syndromes.
    Doyle JA; Connolly SM; Winkelmann RK
    Arch Dermatol; 1982 Nov; 118(11):886-90. PubMed ID: 7138043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.
    Ferreli C; Gasparini G; Parodi A; Cozzani E; Rongioletti F; Atzori L
    Clin Rev Allergy Immunol; 2017 Dec; 53(3):306-336. PubMed ID: 28712039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scleroderma: nomenclature, etiology, pathogenesis, prognosis, and treatments: facts and controversies.
    Fett N
    Clin Dermatol; 2013; 31(4):432-437. PubMed ID: 23806160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presenting characteristics and progression of pediatric-onset morphea: Interim analysis of a prospective registry.
    Ng AT; Brandling-Bennett HA; Drolet BA; Siegel DH; Chiu YE
    Pediatr Dermatol; 2023; 40(4):606-609. PubMed ID: 37317938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphea and localized scleroderma in children.
    Vierra E; Cunningham BB
    Semin Cutan Med Surg; 1999 Sep; 18(3):210-25. PubMed ID: 10468041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palindromic morphea: multiple recurrence of morphea lesions in a case of systemic sclerosis.
    Mizutani H; Tanaka H; Okada H; Mizutani T; Shimizu M
    J Dermatol; 1992 May; 19(5):298-301. PubMed ID: 1644954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel multispectral imaging to predict disease progression in pediatric morphea.
    O'Connor C; McCarthy S; Kiely L; McAuliffe MAP; Bennett M
    Pediatr Dermatol; 2024; 41(2):229-233. PubMed ID: 38305508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis.
    Fett N; Werth VP
    J Am Acad Dermatol; 2011 Feb; 64(2):217-28; quiz 229-30. PubMed ID: 21238823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies in Morphea: An Update.
    Khatri S; Torok KS; Mirizio E; Liu C; Astakhova K
    Front Immunol; 2019; 10():1487. PubMed ID: 31354701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localized and systemic scleroderma.
    Hawk A; English JC
    Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.